Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody
July 1, 2026
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody